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shRNAWe have previously shown a higher level of HIV-1 replication and gene expression in neonatal (cord) blood
mononuclear cells (CBMC) compared with adult blood cells (PBMC), which could be due to differential
expression of host factors. We performed the gene expression proﬁle of CBMC and PBMC and found that
8013 genes were expressed at higher levels in CBMC than PBMC and 8028 genes in PBMC than CBMC,
including 1181 and 1414 genes upregulated after HIV-1 infection in CBMC and PBMC, respectively. Several
transcription factors (NF-κB, E2F, HAT-1, TFIIE, Cdk9, Cyclin T1), signal transducers (STAT3, STAT5A) and
cytokines (IL-1β, IL-6, IL-10) were upregulated in CBMC than PBMC, which are known to inﬂuence HIV-1
replication. In addition, a repressor of HIV-1 transcription, YY1, was down regulated in CBMC than PBMC and
several matrix metalloproteinase (MMP-7, -12, -14) were signiﬁcantly upregulated in HIV-1 infected CBMC
than PBMC. Furthermore, we show that CBMC nuclear extracts interacted with a higher extent to HIV-1 LTR
cis-acting sequences, including NF-κB, NFAT, AP1 and NF-IL6 compared with PBMC nuclear extracts and
retroviral based short hairpin RNA (shRNA) for STAT3 and IL-6 down regulated their own and HIV-1 gene
expression, signifying that these factors inﬂuenced differential HIV-1 gene expression in CBMC than PBMC.te, Seattle, WA 98109, USA.
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HIV-1 infection in neonates and infants occurs as a result of
mother-to-infant transmission of the virus during gestation at the
time of birth and via breast milk (Chouquet et al., 1997; Kwiek et al.,
2008; Lehman et al., 2008; Little et al., 2007; Mock et al., 1999;
Schwartz et al., 1995; Zijenah et al., 2004). Moreover, HIV-1 infected
infants have a higher level of viremia and develop AIDS more rapidly
than infected adults, including differences seen in clinical manifesta-
tions (Belman, 1997; Epstein et al., 1985; Resino et al., 2000; Tovo
et al., 1992). Most infected infants show symptomatic AIDS symptoms
quickly as opposed to adults where clinical latency prolongs for a
longer time (MaWhinney et al., 1993; Tovo et al., 1992). However, the
underlying molecular mechanisms of a high viral load and rapid
disease progression in infants are still poorly understood. In this
context, we have previously shown a higher level of HIV-1 replication
in neonatal mononuclear cells compared with adult cells (Sundar-
avaradan et al., 2006). We have further shown that this increased viral
replication in neonatal (cord) blood mononuclear cells vs. adult cells is
inﬂuenced at the level of HIV-1 LTR driven gene expression (Sundar-
avaradan et al., 2006). These data suggest that differential levels ofcellular factors are inherently present or modulated after HIV-1
infection in neonatal vs. adult cells, which inﬂuence HIV-1 gene
expression and replication in these hosts cell types.
During infection, HIV-1 drives a vast program of host cell factors
that redirect cellular machinery and interfere with cellular pathways
that are not conducive to viral survival (Copeland, 2005; Gaynor,
1992). However, the global effects of HIV-1 infection on host cell gene
expression have not been comprehensively addressed and under-
standing the biochemical changes that occur in HIV-1 infection is
important for continuing efforts aimed at countering its effects. HIV-1
encoded proteins have been shown to interact with cellular proteins
and modulate host cell responses to regulate viral persistence or
productive infection. HIV-1 LTR utilizes a combination of cellular
factors and viral proteins to regulate early HIV-1 gene expression after
primary infection (Molle et al., 2007; Roebuck and Saifuddin, 1999;
Sheppard et al., 1999; Stevens et al., 2006; van 't Wout et al., 2003;
Zhou et al., 2001). HIV-1 LTR contains several sites for binding of host
transcription factors, including NF-κB, NF-AT, AP1, SP1, USF-1, Ets-1
and NF-IL6 (Gaynor, 1992; Molle et al., 2007; Pereira et al., 2000). The
NF-κB protein acts in concert with HIV-1 Tat and some host
transcriptional regulators, including Cdk9, TFIIH, Cyclin T1, P-TEFb,
HAT-1 and p300 to cause a multifold increase in of viral gene
expression (Cereseto et al., 2005; Coull et al., 2000; Molle et al., 2007;
Stevens et al., 2006; Topper et al., 2007). HIV-1 acute infection may
cause aberrant expression of host genes that may be responsible for
the evasion of host immunity, such as upregulation of interferon
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genes (Kohler et al., 2003). In cell lines, as early as 24 h post-infection,
HIV-1 can inﬂuence genes involved in cell division, apoptosis, protein
expression, RNA splicing and translation (van 't Wout et al., 2003).
However, host protein YY1 has been shown to repress HIV-1 gene
expression (Buckner et al., 2002; Coull et al., 2000; El Kharroubi et al.,
1998; He and Margolis, 2002). HIV-1 infected infants and adults
exhibit signiﬁcant differences in viral replication kinetics and disease
outcomes (Little et al., 2007; Sundaravaradan et al., 2006). There is a
strong possibility that differential levels or expression of cellular
factors in neonatal vs. adult mononuclear cells, including transcrip-
tional factors; and the interplay between viral proteins and host
transcription machinery may be responsible for the increase in levels
of HIV-1 gene expression in neonatal cells.
While some studies have analyzed the host gene expression proﬁle
in HIV-1 infected adult blood mononuclear cells (PBMC), host gene
expression proﬁle in neonatal cells and a comparative study between
these two systems is lacking. We, therefore, sought to perform a
comparative analysis of the host gene expression proﬁle of neonatal
and adult blood mononuclear cells before and during HIV-1 infection
in order to identify the relevant host factors that contribute to
differential HIV-1 gene expression and replication in neonatal and
adult cells. We have used cord blood in place of neonatal blood
because, like neonatal blood, it has more CD45RA+ T-lymphocytes
and less CD45RO+ T-lymphocytes and is more immature compared
with adult blood (Harris et al., 1992; Mo et al., 1998).
Usingmicroarray technology (Gershon, 2002), we have performed
a comparative analysis of the host gene expression proﬁle in
uninfected and HIV-1 infected adult blood mononuclear cells
(PBMC) and neonatal (cord) blood mononuclear cells (CBMC). This
study includes cellular gene expression proﬁle analysis of PBMC and
CBMC which are (a) freshly isolated (to study inherent differences);
(b) stimulated cells (to examine mRNA expression just prior to
infection) and (c) infected cells (for infection mediated modulation).
We show that several transcriptional factors and activators (NF-κB,
HAT1EF2, TFIIE, Cdk9, Cyclin T1), signal transducers (STAT3, STAT5A),
cytokines (IL1β, IL-6, IL-10) and matrix metalloproteinase were
expressed at higher levels in unstimulated, PHA-stimulated and
HIV-1 infected cord blood mononuclear cells compared with adult
blood cells. Several of these factors are known to inﬂuence HIV-1 gene
expression and replication. We have utilized electro-mobility gel shift
assay (EMSA) to show that cord blood mononuclear cells nuclear
extracts interact with a higher extent to HIV-1 LTR cis-acting se-
quences, including NF-κB, NFAT, AP1 and NF-IL6 compared with adult
cells extracts, suggesting that these factors inﬂuence increased HIV-1
gene expression in cord vs. adult cells. Furthermore, we show that
retroviral based short hairpin RNA (shRNA) for STAT3 and IL-6 down-
modulated the expression of these genes and HIV-1 gene expression.
Taken together, the differential host gene expression proﬁle and
interaction of several transcriptional factors with the HIV-1 LTR as well
as interference of some these host factors with HIV-1 gene expression
show that these factors inﬂuence increased HIV-1 gene expression in
cord vs. adult cells.
Results
Differential gene expression proﬁle of unstimulated, stimulated and
HIV-1 infected CBMC and PBMC
We ﬁrst determined HIV-1 gene expression by infecting CBMC and
PBMC from ﬁve different donors by using a single cycle replication
competent HIV-1-NL-Luc-E-R (Connor et al., 1995) and measuring
luciferase and found that there was higher levels of HIV-1 gene
expression in CBMC compared with PBMC (not shown), as also
reported before in our previous study with T-lymphocytes and
macrophages (Sundaravaradan et al., 2006). We then determinedthe cellular gene expression proﬁle of unstimulated, PHA-stimulated,
and HIV-1 infected CBMC and PBMC by microarray analysis, as
described in the methods. These microarray analyses were repeated
ﬁve times to ensure reproducibility in the identiﬁcation of cellular
factors that were differentially expressed in CBMC vs. PBMC.
A representative scatter plot data of the microarray as obtained
from Gene Spring is shown in Fig. 1. The CBMC data is plotted on the
Y-axis and the PBMC data on the X-axis. Expressed genes are shown as
dots with arbitrary coloration of red used for genes expressed higher
in CBMC and green used for genes expressed higher in PBMC. As
shown in Fig. 1, genes expressed equally in CBMC and PBMC appear
along the diagonal as yellow dots. All genes that were expressed
higher than 2-fold in either CBMC or PBMCwere included in the study
with primary focus on genes expressed at higher levels in CBMC. As
estimated by Gene Spring, in stimulated cells, 8028 genes showed
over 2-fold higher expression in PBMC over CBMC and 8013 genes
were expressed at higher level in CBMC over PBMC. Of these genes,
HIV-1 infection caused 1181 genes to be upregulated in CBMC and
1414 genes were upregulated in PBMC. Although such a signiﬁcant
number of genes were identiﬁed, it is important to know the class of
genes that are upregulated and how they may affect HIV-1 replication
and gene expression. The differentially regulated genes were then
sorted based on their capacity to regulate cell cycle progression,
increase transcription, control apoptosis and other similar pathways.
Cellular gene expression proﬁle of transcription factors differentially
expressed in CBMC and PBMC
To analyze the classes of cellular genes that were expressed at a
higher level in CBMC vs. PBMC, algorithms that classify these genes
based on functionality was used in the Gene Spring Program. As shown
in Table 1, several transcription factors are expressed at higher levels in
CBMC as compared to PBMC. We observed that critical transcription
factor NF-κB was expressed at higher levels in unstimulated (8-fold),
stimulated (8-fold) and infected (16-fold) CBMC as compared to PBMC.
Factors that inﬂuence Tat recruitment at the viral LTR including Cdk9
and Cyclin T1 showed increased expression in unstimulated and
stimulated CBMC. Cellular factors that allow chromatin remodeling
such asHAT-1 also showed consistent 2-fold higher expression in CBMC
as compared to PBMC in unstimulated, stimulated and infected cells.
Transcription factor YY1 has been shown to repress HIV-1 LTR
dependent transcription (He and Margolis, 2002). Table 1 shows that
CBMC showed decreased expression of transcriptional repressor YY1
as compared to expression in PBMC. We were able to observe that
stimulation and infection of CBMC and PBMC led to decreased YY1
expression in CBMC. Furthermore, upon stimulation, there was a
2-fold lower level of YY1 in CBMC as compared to PBMC. This fold
change was not as marked in unstimulated and infected CBMC even
though the expression of YY1 was always lower in CBMC as compared
to PBMC (data not shown). This differential expression of YY1 in CBMC
and PBMC in context to stimulation could play a role in relieving
repression of HIV-1 LTR.
Our experiments have indicated that there are critical differences
in the expression levels of several transcription factors in CBMC and
PBMC. We have observed that unstimulated and stimulated CBMC
expressed 2-fold higher levels of transcription factors, including TFIIH
and TFIIE, when compared with unstimulated and stimulated PBMC.
Other general transcription factors such as ATF-4, GCN5 and E2F were
expressed at 2- to 5-fold higher in unstimulated, stimulated and
infected CBMC as compared to PBMC (Table 1). All fold changes seen in
the microarray data were signiﬁcant (pb0.05) as measured by t-test
during Gene Spring analysis. As the microarray experiments were
performed in the sameCBMC-PBMC sample pairswhich demonstrated
differential level of luciferase expression, the differences seen in these
transcription factors signiﬁcantly contribute to the differential gene
expression as shown previously (Sundaravaradan et al., 2006).
Fig. 1. Scatterplot of the normalized ﬂuorescent intensities of CBMC on the Y-axis and PBMC on the X-axis. The axes are represented in a log-scale and each dot on the graph
represents one gene. The position of each dot (gene) on the graphs was determined by ratio of its message in CBMC RNA vs. PBMC RNA. The colors of the dots are random coloring
where red dots indicate increase fold in CBMC and the green dots indicate increase fold in PBMC. The graphs also show fold change lines +6,+4,+2,1,−2,−4,−6 from top to
bottom. A positive fold change indicates higher level in CBMC and negative fold change indicates lower level in CBMC (or higher level in PBMC as the dots positions are ratio of CBMC
over PBMC). 1 fold indicates the genes were equally expressed in CBMC and PBMC.
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and PBMC
Signal transducers that are known to generally upregulate
eukaryotic transcription were also expressed at higher levels in
CBMC as compared to PBMC. Signal transduction molecules STAT3
and STAT5Awere expressed 2-fold higher in unstimulated, stimulated
and infected CBMC as compared to PBMC. The higher expression of
these transcription factors that upregulate transcription may indicate
an environment conducive for higher HIV-1 LTR based transcription in
cord blood cells compared to adult blood cells.
Several pro-inﬂammatory cytokines and their antagonists were
consistently over expressed in CBMC as compared to PBMC in
unstimulated, stimulated and infected cells. Pro-inﬂammatory cyto-
kines such as IL-1β and IL-6 were expressed 3- to 16-fold higher in
CBMC as compared to PBMC. These cytokines have been shown to play
signiﬁcant roles in HIV-1 associated dementia, which is a common
clinical outcome of HIV-1 infected infants. Cytokines such as IL-10,
which acts as an antagonist of pro-inﬂammatory cytokines such as IL-6,
were also expressed at higher levels in CBMC than in PBMC. Very high
levels of IL-10 are inhibitory to HIV-1 replication, however, moderate
levels have been shown to support replication (Wang and Rice, 2006).
Although cytokines such as IFN-γ and TNF-α were not overexpressed
in CBMC, the receptors for these cytokines were expressed at higher
levels in CBMC as compared to PBMC. Chemokines that compete with
HIV-1 such as MIP-1α and MIP-1β were expressed at same levels in
CBMCandPBMC. The receptors for these chemokines, CXCR4andCCR5,which are used for HIV-1 viral entry were also expressed at similar
levels in CBMC and PBMC as found in our previous study by ﬂow
cytometery (Sundaravaradan et al., 2006).
Matrix mettaloproteinases (MMP) are usually secreted by host
cells in response to viral replication and viral proteins (Webster and
Crowe, 2006). Some MMP such as MMP2 and MMP7 are associated
with signiﬁcant neural degeneration and HIV-associated dementia
(HAD) in infants (Sevigny et al., 2007; Zhang et al., 2003). Our data
indicate that there is signiﬁcant overexpression of MMP in CBMC vs.
PBMC. MMP7, which can cause HAD and CD4 apoptosis by a Fas-FasL
pathway (Lugli et al., 2005), was expressed 76-fold higher in CBMC as
compared to PBMC. This overexpression was consistently seen in all
our experiments. AlthoughMMPare not implicated in increasedHIV-1
replication, their dysregulation is indicative of faster disease progres-
sion. Thus the expression proﬁle of MMP seen in CBMC could be
predictive of adverse disease progression in neonates infected with
HIV-1. Taken together, the differential cellular gene expression proﬁle
of signal transducers, cytokines and their receptors and MMP could
provide an environment that could inﬂuence the increased HIV-1
replication and HIV-1 gene expression seen in CBMC vs. PBMC.
Real-time RT-PCR quantiﬁcation of differential cellular gene expression
proﬁle in CBMC and PBMC
Microarray analysis is a quantitative tool to estimate differential
cellular gene expression proﬁle between two experimental setups
such as CBMC and PBMC. However, the fold change as seen by
Table 1
Differential expression of cellular genes in unstimulated, stimulated and HIV-infected
CBMC and PBMC.
Gene name Unstimulated Stimulated Infected
Transcriptional activators
NF-κB +8-fold +8-fold +16-fold
HAT-1 +2-fold +2-fold +2-fold
ATF-4 +2-fold +2-fold +2-fold
GCN5 +2-fold +2-fold +2-fold
E2F +5-fold +1.3-fold +3-fold
TF IIE +2-fold +2-fold Unchanged
TF IIH +2-fold Unchanged Unchanged
Cdk9 +2-fold Unchanged Unchanged
Cyclin T1 +2-fold +2-fold Unchanged
YY1 −1.2-fold −2-fold −1.6-fold
Cytokines and receptors
IL1β +3-fold +5-fold +18-fold
IL-6 +5-fold +5-fold +5-fold
IL-10 +4-fold +2-fold +2-fold
Small inducible cytokine A2 +2-fold +2-fold +2.5-fold
TNF-α Unchanged Unchanged Unchanged
IFN-γ Unchanged Unchanged Unchanged
MIP-1α Unchanged Unchanged Unchanged
MIP-1β Unchanged Unchanged Unchanged
TGF-β Unchanged Unchanged Unchanged
IFN-γ receptor 2 +3-fold +2-fold +3-fold
IL22 receptor +2-fold +2-fold +2-fold
TNF-α receptor +2-fold +2-fold +2-fold
CXCR4 Unchanged Unchanged Unchanged
CCR5 Unchanged Unchanged Unchanged
Signal transducers
STAT3 +2-fold +2-fold +2-fold
STAT 5A +2-fold +2-fold +2-fold
Matrix mettaloproteinases
MMP12 +3-fold +3-fold +6-fold
MMP14 Unchanged Unchanged +2-fold
MMP7 Unchanged Unchanged +76-fold
Note. (+) indicates higher expression in CBMC as compared to PBMC, whereas (−)
indicates lower expression in CBMC than in PBMC.
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samples due to experiment variables such as dye bias and dye
incorporation. Therefore, it is essential to accurately estimate the fold
changes seen in CBMC and PBMC by a much more sensitive method
such as real-time RT-PCR, which estimates the levels of gene targets in
the sample by performing a PCR with a double stranded DNA dye
whose levels are estimated after every cycle of ampliﬁcation.
We have performed real-time RT-PCR estimation of fold changes
seen between CBMC and PBMC for several genes that directly interact
with the viral LTR and those that interactwith LTR transcription factors
via protein–protein interactions. Each ampliﬁcation of the gene of
interest and GAPDH (housekeeping gene) was performed in triplicate
to ensure replicates and to accurately estimate fold changes. As seen in
Table 2, we have conﬁrmed the fold changes seen in our microarray
experiments for transcription factors that directly inﬂuence HIV-1 LTRTable 2
Real-time PCR analysis of fold change differences seen in gene of interests.
Experiment Genes Ct values (PBMC) Ct values (CBMC)
Unstimulated NF-κB 24.32 27.63
STAT3 21.19 22.63
Cdk9 17.69 18.97
Stimulated NF-κB 24.03 26.92
STAT3 21.34 22.47
Cdk9 16.37 16.45
Infected NF-κB 26.05 30.12
STAT3 22.01 22.97such as NF-κB and Cdk9. We have also conﬁrmed the increased
expression of the factors that upregulate general transcription such as
STAT3. As these real-time RT-PCR experiments are performed in the
same RNA samples thatwere used for themicroarray experiments, the
real-time RT-PCR results efﬁciently validate our fold changes seen in
our microarray experiments.
Interaction of cellular factors from cord and adult mononuclear cells
with HIV-1 LTR
Upon HIV-1 integration into the host chromosome, basal tran-
scription begins when cellular factors such as NF-κB bind to the HIV-1
LTR. Increased mRNA expression of cellular factors that interact with
HIV-1 LTR (Table 1) may not be considered conclusive to explain the
differential level of transcription seen at the HIV-1 LTR in CBMC vs.
PBMC. We sought to determine the interaction of nuclear extracts
from the mononuclear cells of cord and adult blood with HIV-1 LTR by
electrophoretic mobility shift assays (EMSA). The assays were
performed using equal amount of nuclear extracts (as measured by
amount of protein) with designer DNA probes based on the consensus
sequence of HIV-1NL4-3 LTR for NF-κB, NF-IL6, NFAT, AP-1, and Sp1.
Performing cold competition assays with 10× or 100× of cold probe
ensured validity of the binding speciﬁcity. Fig. 2A shows that cellular
factors from cord nuclear extracts bind to a higher extent to HIV-1 LTR
compared to adult nuclear extracts. Lanes 4 and 8 show increased
binding of cord nuclear extracts with the NF-κB probe as compared to
adult nuclear extracts. Cold competition assays were also performed
as indicated with 10X and 100X of cold probe (Fig. 2A, lanes 9 and 10)
as well as a non-speciﬁc 100X cold NFAT probe to show speciﬁcity
(data not shown). Interestingly, the effect of stimulation is also seen in
these studies with the NF-κB probe. The increased binding found in
cord extracts in stimulated cells than in unstimulated cells as
compared to adult suggests there is a higher concentration of NF-κB
that is available to bind to the LTR in unstimulated and stimulated
cord nuclear extracts as compared to adult unstimulated and
stimulated nuclear extracts. This supports our ﬁnding of increased
levels of NF-κB in stimulated CBMC (Table 1). As the total protein was
normalized, the increase in NF-κB protein in the cellular extracts
validates the increase in mRNA assessed in the microarray experi-
ments. We have also shown an extent of higher binding of the cord
nuclear extract with NFAT, NF-IL6, and AP-1 (Figs. 2B–D) as compared
to nuclear extracts from PBMC. Binding experiments using the Sp1
probe with nuclear extracts from CBMC and PBMC showed similar
level of Sp1 (Fig. 2E) binding in both the nuclear extracts. This is
similar to our ﬁnding in the microarray that showed same level of Sp1
expression in CBMC and PBMC. We conﬁrmed the binding intensities
by using ImageJ available at the NIH website. The differential binding
proﬁle of CBMC and PBMC extracts with HIV-LTR correlated with the
gene expression proﬁle obtained by microarray analysis. Taken
together, these results suggest that increased expression of several
host transcription factors and their differential binding efﬁciencies to
HIV-1 LTR contribute to an increased HIV-1 LTR based transcription in
CBMC compared with PBMC.Ct values (GAPDH-PBMC) Ct values (GAPDH-CBMC) Fold change
34.61 34.52 23.18=9
21.4=2
21.2=2
33.63 33.73 22.9=8
20.9=2
20.1=1
33.97 33.89 24.0=16
20.7∼2
Fig. 2. EMSA of nuclear extracts from CBMC and PBMC binding to HIV-1 LTR. (A) NFκB. Lanes: 1, probe only; 2, HeLa extract + probe; 3, Cord Unstimulated (US) + probe; 4, Cord
Stimulated (S) + probe; 5, Cord S + probe + 10×; 6, Cord S + probe + 100×; 7, Adult Unstimulated (US) + probe; 8, Adult Stimulated (S) + probe; 9, Adult S + probe + 10×; 10,
Adult S+probe+100×. Cold competition for Cord andAdult US extractswas also performed (not shown). (B) NFAT. Lanes: 1, probe only; 2, HeLa extract+probe; 3, HeLa+probe+
100× cold probe; 4, Adult US + probe; 5, Adult US + probe + 100×; 6, Adult S + probe; 7, Adult S + probe + 100×; 8, Cord US + probe; 9, Cord US + probe + 100×; 10, Cord S +
probe; 11, Cord S + probe + 100×. (C) NF-IL6. Lanes: 1, probe only; 2, HeLa extract + probe; 3, HeLa + probe + 10× cold probe; 4, HeLa + probe + 100× cold probe; 5, Adult
Unstimulated (US) + probe; 6, Adult US+ probe + 10×; 7, Adult US + probe + 100×; 8, Adult Stimulated (S) + probe; 9, Adult S + probe + 10×; 10, Adult S + probe + 100×; 11,
Cord US+probe; 12, Cord US+probe+10×; 13, Cord US+probe+100×; 14, Cord S+ probe; 15, Cord S+ probe+10×; 16, Cord S+probe+100×. (D) Ap1. (E) SpI. For D and E:
Lanes: 1, probe only; 2, HeLa extract+probe; 3, HeLa+probe+100× cold probe; 4, Adult US+probe; 5, Adult US+probe+100×; 6, Adult S+probe; 7, Adult S+probe+100×; 8,
Cord US + probe; 9, Cord US + probe + 100×; 10, Cord S + probe; 11, Cord S + probe + 100×.
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HIV-1 replication and disease progression are inﬂuenced by
several host factors, some of which were seen to be expressed at
higher levels in CBMC compared to PBMC, including host factors IL-6
and STAT3. IL-6 is know to indirectly inﬂuence HIV-1 transcription by
activating NF-IL6 (Taga and Fukuda, 2005) which binds to the HIV-1
LTR and upregulate viral transcription. It is known that STAT3 can
bind to the LTR and activate HIV-1 transcription (Kohler et al., 2003).
In addition, NF-IL6 can also bind to the IL-6 promoter and increase IL-6
mRNA production in a positive feedback loop (Akira et al., 1992).
Some of the factors that were identiﬁed in this study have known
effects in upregulating HIV-1 gene expression and the increased
expression of these factors in CBMC could be playing a role in
increased HIV-1 replication and gene expression in neonates. We
chose to study IL-6 and STAT3 in HIV-1 infection of primary cells as
these factors have been previously shown to affect HIV-1 infection in
cell lines (Klatt et al., 2007).
We stimulated CD4+ T-lymphocytes for 24–36 hwith PHA and IL-2
and then infected cells with either IL-6 speciﬁc shRNA or STAT3
speciﬁc shRNA retroviral vectors. After introduction of the speciﬁc/
nonspeciﬁc shRNA via retroviral vector, we infected the same cells
with HIV-NL-Luc-E−R+. Fig. 3A shows the effect of IL-6 speciﬁc shRNA
onHIV-1 gene expression in CD4+ T-lymphocytes from cord and adult
blood. It can be seen that introduction of IL-6 shRNA, markedly lowers
IL-6mRNA levels as conﬁrmed by RT-PCR (Fig. 3B) and decreases HIV-
1 gene expression in both cord and adult cells (Fig. 3A). TubulinRT-PCR
was performed as a control (Fig. 3C).
Figure 4A shows the effect of STAT3 speciﬁc shRNA on HIV-1 gene
expression in CD4+ T-lymphocytes from cord and adult blood.
We observed that the down modulation of STAT3 mRNA (Fig. 4B)
by STAT3 shRNA decreases HIV-1 gene expression in both cord and
adult CD4+ T-lymphocytes. This is a similar decrease as found in IL-6
shRNA experiments showing that in cord and adult blood CD4+ T-
lymphocytes STAT3 and IL-6 both play important roles in HIV-1 LTRmediated gene expression. Tubulin RT-PCR was performed to ensure
ampliﬁcation was done equally (Fig. 4C). To ensure that this down-
modulation was speciﬁc to the gene sequences that we have used and
not a generalized down-modulation of the lentiviral vector, we also
performed similar experiments separately for cord and adult cells
with the non-speciﬁc (scrambled) shRNA for IL-6 and STAT3. Fig. 5A
shows that the non-speciﬁc shRNA sequences to neither IL-6 nor
STAT3 alter the luciferase expression in either cord or adult CD4+ T-
lymphocytes. In addition, we performed RT-PCR to detect mRNA
levels of IL-6 (5B), STAT3 (5C) and tubulin (5D). The results do not
show any signiﬁcant difference in expression of IL-6 or STAT3 in cells
treated with non-speciﬁc shRNA sequences as compared with
untreated cells suggesting that the down-modulation by the retroviral
vector alone is not responsible for the downmocultion of IL-6 or
STAT3 mediated effects on HIV-LTR in cord and adult blood.
Comparing the downregulation of HIV-1 gene expression between
T-lymphocyte cell line A3.01 (data not shown) and primary cells we
see the effect of introducing speciﬁc shRNAs drastically alters
transcriptional regulation more in primary cells than in A3.01 cells.
This suggests that cellular factors IL-6 and STAT3 are critical regulators
of HIV-1 gene expression. Results of the shRNA studies in cord and
adult blood CD4+ T-lymphocytes may provide a stepping stone for
researchers to try and target host factors such as IL-6 and STAT3 for
therapeutic strategies.
Discussion
We provide evidence that there is a differential host gene
expression proﬁle in neonatal (cord) and adult blood mononuclear
cells before and after stimulation as well as after HIV-1 infection,
which may inﬂuence a higher level of viral replication and gene
expression in cord vs. adult cells (Sundaravaradan et al., 2006).
Speciﬁcally, we found that several transcriptional factors (NF-κB,
HAT1, ATF-4, GCN5, E2K, YY1), signal transducers (STAT3, STAT5A),
cytokines (IL-1β, IL-4, IL-10) and matrix metalloproteinase (MMP 7,
Fig. 3. Effect of IL-6 shRNA on HIV-1 gene expression in cord and adult CD4+ T-lymphocytes (A). Enriched CD4+ T-lymphocytes from cord and adult blood were infected with
100,000 RT counts of IL-6 shRNA retroviral vector and allowed to incubate for 12–16 h. The same cells were then infected with 100,000 RT counts of HIV-NL-Luc-E-R+ and lysed 72 h
post infection and luciferase assays were performed. (B and C) IL-6 and Tubulin RT-PCR. Lane 1, ladder; lanes 2 and 3, CD4+ T-lymphocytes; lanes 4 and 5, CD4+ T-lymphocytes + IL-
6 shRNA; lane 6, negative control.
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and several of these factors are known to inﬂuence HIV-1 gene
expression and replication (Bosinger et al., 2004; Kedzierska et al.,
2003; Kohler et al., 2003;Molle et al., 2007; Pereira et al., 2000; Stevens
et al., 2006). To show biological relevance of several of these factors
with HIV-1, we have shown that CBMC nuclear extracts interacted
with a higher extent to HIV-1 LTR cis-acting sequences, including NF-
κB, NFAT, AP1 and NF-IL6 compared with PBMC extracts, suggesting
that these factors inﬂuence increasedHIV-1 gene expression in cord vs.
adult cells (Sundaravaradan et al., 2006). Furthermore, to assess the
function of immunomodulatory proteins that do not directly bind the
HIV-LTR, we show that retroviral based short hairpin RNA (shRNA) for
IL-6 and STAT3 down-modulated the expression of these genes and in
turn suppressed HIV-1 gene expression, suggesting that these factors
inﬂuence HIV-1 gene expression. These ﬁndings suggest that differ-
ential HIV-1 replication and gene expression in cord vs. adult cells
(Sundaravaradan et al., 2006), as well as higher viral load and more
rapid disease progression in neonates and infants than adults (Little
et al., 2007; MaWhinney et al., 1993; Tovo et al., 1992) could be
inﬂuenced by differential host gene expression proﬁle in neonatal
(cord) vs. adult cells and their functional interactions with HIV-1.
Our data shows that almost all transcription factors that play
signiﬁcant roles in transcription at the HIV-1 LTR were upregulated in
CBMC compared with PBMC. NF-κB is an important transcription
factor for HIV-1 LTR transcription (Furia et al., 2002; Nabel and
Baltimore, 1987; Sheppard et al., 1999) and lack of NF-κB in cells or
mutations in the NF-κB sites in HIV-1 LTR signiﬁcantly decreases orabrogates viral transcription. Signiﬁcant increases in NF-κB levels
(Table 1) in unstimulated, stimulated and HIV-1-infected CBMC vs.
PBMC suggest that NF-κBmay contribute to a considerable increase in
viral gene expression, as seen in CBMC compared with PBMC
(Sundaravaradan et al., 2006). Some other factors such as Cdk9 and
Cyclin T1 are essential for HIV-1 transcription in the presence of Tat
(Liou et al., 2004; Molle et al., 2007; Rice and Herrmann, 2003; Zhou
et al., 2001) and a 2-fold increase seen in CBMC vs. PBMC (Table 1)
may allow HIV-1 LTR transcription to occur at higher levels in CBMC
compared to PBMC. Also, histone acetyl transferase (HAT-1) helps
unwinding of chromatin at nucleosome 1 located on HIV-1 LTR
(Cereseto et al., 2005; Topper et al., 2007). We found that HAT-1 was
expressed at higher levels in CBMC than PBMC (Table 1), which may
allow for a more open chromatin structure at the LTR facilitating the
recruitment of transcriptional machinery and a higher level of gene
expression in CBMC than PBMC.
Transcriptional repressors such as Yin-Yang1 (YY1) can down-
regulate HIV-1 transcription (He and Margolis, 2002; Margolis et al.,
1994). In this study, we have found that transcriptional repressor of
HIV-1, YY1 (Coull et al., 2000; El Kharroubi et al., 1998; Margolis et al.,
1994), was expressed at a lower level in CBMC compared with PBMC.
In addition, this slight difference in unstimulated CBMCwas increased
to up to 2-fold in stimulated cells. This higher rate of decrease of YY1
in CBMC than PBMC could also indicate that the repression of
transcription was more rapidly relieved in CBMC than PBMC, allowing
higher levels of HIV-1 gene expression in CBMC than PBMC
(Sundaravaradan et al., 2006). This differential proﬁle of transcription
Fig. 4. Effect of STAT3 shRNA on HIV-1 gene expression in cord and adult CD4+ T-lymphocytes (A). Enriched CD4+ T-lymphocytes from cord and adult blood were infected with
100,000 RT counts of STAT3 shRNA retroviral vector and allowed to incubate for 12–16 h. The same cells were then infectedwith 100,000 RT counts of HIV-NL-Luc-E-R+ and lysed 72 h
post infection and luciferase assays were performed. (B and C) STAT3 and Tubulin RT-PCR. Lane 1, ladder; lanes 2 and 3, CD4+ T-lymphocytes; lanes 4 and 5, CD4+ T-lymphocytes +
STAT3 shRNA; lane 6, negative control.
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expression in CBMC as compared to PBMC.
Several other transcription factor binding sites other than NF-κB in
HIV-1 LTR, including NF-IL6, AP1, NFAT, and Sp1, were not present on
our 22K gene chip. Therefore, we evaluated whether nuclear extracts
from cord and adult cells interacted differently with the LTR. As shown
in Fig. 2, there was a higher level of binding of CBMC nuclear extracts
with NF-κB, NFAT, NF-IL6 and AP1 binding sites compared with PBMC
nuclear extracts, whereas no difference in binding was seen with Sp1
and TAR (not shown) sequences. The level of binding seen with NF-κB
from the cord vs. adult nuclear extracts here and elsewhere (Kedar et
al., 1997) corroborates with the data of microarray analysis where NF-
κB was signiﬁcantly upregulated in CBMC than PBMC (Table 1) and
supports the notion thatNF-κB is critical forHIV-1 transcription (Nabel
and Baltimore, 1987). Nuclear extracts from CBMC also bound to NF-
IL6, NFAT, andAP1with a higher extent compared to PBMC (Fig. 2). It is
known that these factors are a necessity in a productive HIV-1
infection and immediate viral gene expression (Ruocco et al., 1996;
Tesmer and Bina, 1996). Transcription factor NF-IL6 belongs to the C/
EBP family of proteins and is also shown to activate HIV-1 LTR
mediated transcription (Ruocco et al., 1996). Similarly, NFAT and Ap1
are also known to enhance HIV-1 LTR mediated gene expression
(Roebuck and Saifuddin, 1999; Stevens et al., 2006). Our data suggest
that a higher extent of bindingofNF-κB,NF-IL6, NFAT, andAP-1 toHIV-
1 LTR from nuclear extracts of CBMC compared to PBMC contributes to
an increased HIV-1 gene expression and replication in CBMC vs. PBMC
(Sundaravaradan et al., 2006).Cytokines and chemokines play important roles in regulatingHIV-1
replication. During the course of HIV-1 infection, secretion of T-helper
1 (Th1) cytokines is generally decreased, whereas production of
T-helper 2 (Th2) cytokines and pro-inﬂammatory cytokines is
generally increased (Copeland, 2005; Kedzierska et al., 2003). Such
dysregulation in cytokine production contributes to the pathogenesis
of the disease by impairing cell-mediated immunity. Microarray
analysis of unstimulated, stimulated and HIV-1 infected CBMC and
PBMC have shown differential expression of several cytokines that
inﬂuence HIV-1 infection. Table 1 shows that pro-inﬂammatory
cytokines such as IL-1β and IL-6 were expressed 3- to 18-fold higher
in unstimulated, stimulated, and HIV-1 infected CBMC as compared to
PBMC. As IL-1β and IL-6 induce viral mRNA production during HIV-1
infection the increased production of both IL-1β and IL-6 in CBMC
could be predictive of increased HIV-1 gene expression seen in cord
blood MDM and lymphocytes. IL-1β in the context of HIV-1 infection
can also induce FasL via the NF-κB pathway (Ghorpade et al., 2003).
Cytokines induce transcription of several transcription factors such as
NF-IL6 that is induced by both IL-1 and IL-6 (Akira et al., 1992). NF-IL6
has binding sites in several genes, including IL-1, IL-6 and the HIV-1
LTR (Akira et al., 1992; Copeland, 2005). Higher levels of IL-1 and IL-6
in CBMC than PBMC can increase the expression of NF-IL6 in a positive
feedback loop leading to upregulation of HIV-1 gene expression
CBMC. Our EMSA experiments clearly indicated an increased binding
of NF-IL6 in CBMC extracts as compared to PBMC, which lends weight
to our ﬁndings with IL-1 and IL-6 levels. Furthermore, there was also a
higher expression of IL-10 in unstimulated, stimulated and infected
Fig. 5. Effect of non-speciﬁc shRNA on cord and adult CD4+ T-lymphocytes. (A) Enriched CD4+ T-lymphocytes from cord and adult blood were infected with 200 ng p24 of either
non-speciﬁc IL-6 shRNA (IL6s) or non-speciﬁc STAT3 shRNA (STAT3s) and allowed to incubate for 12–16 h. The same cells were then infected with 200 ng p24 of HIV-NL-Luc-E-R+
and lysed 72 h post infection and luciferase assays were performed. RT-PCR was performed for IL-6 (B), STAT3 (C) and Tubulin (D). Lane 1, Cord CD4+ T-lymphocytes; lane 2,
Cord CD4+ T-lymphocytes + non-speciﬁc IL-6 shRNA; lane 3, Cord CD4+ lymphocytes + non-speciﬁc STAT3 shRNA; lane 4, Adult CD4+ T-lymphocytes; lane 5, Adult CD4+ T-
lymphocytes + non-speciﬁc IL-6 shRNA; lane 6, Adult CD4+ T-lymphocytes + non-speciﬁc STAT3 shRNA; lane 7, negative control.
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inﬂammatory cytokines such as IL-1β and IL-6, has been previously
shown to act with IL-1β and IL-6 allowing increased transcription of
viral mRNA during HIV-1 infection (Kinter et al., 2001; Poli et al.,
1994). Thus, increased production of IL-10 in CBMC may also
inﬂuence increased HIV-1 gene expression in CBMC. In addition,
increased production of IL-6 and IL-10 in CBMC suggest a predispo-
sition in the immature immune system to the Th2 pathway, which is
ineffective in controlling HIV-1 replication and pathogenesis in
infected patients. The increased expression of these cytokines in
CBMC than PBMCmay contribute to a higher level of HIV-1 replication
in CMBC than PBMC.
Our data on down modulation of IL-6 and STAT3 by their
respective shRNA and interference in HIV-1 gene expression with a
differential effect in cord vs. adult cells underscores the importance of
these genes in HIV-1 replication. It is known that IL-6 in conjunction
with IL-1 can induce HIV-1 replication in chronically infected cells
(Poli et al., 1994) and in turn IL-6 can activate signaling through the
JAK–STAT pathway (Horvath, 2004). This signaling activates STAT3,
which dimerizes and localizes to the nucleus where it can bind to
several host genes increasing their transcription (Reich and Liu,
2006). Using our retroviral system to introduce to down-modulate
these cellular factors IL-6 and STAT3 in cord and adult CD4+ T-
lymphocytes, we saw that a down-modulation of IL-6 and STAT3
expression signiﬁcantly altered HIV-1 gene expression which was
markedly decreased in CD4+ T-lymphocytes when treated with
speciﬁc shRNA against either IL-6 or STAT3 shRNA (Figs. 3 and 4). It
was also observed that this down-modulation was speciﬁc as
luciferase expression in cells treated with non-speciﬁc shRNA
sequences showed no signiﬁcant difference compared to the
luciferase expression of the R+ vector alone (Fig. 5). Others have
shown that introduction of STAT3 siRNA into PBMC before infection
with HIV-1LAV (X4) or HIV-1BaL (R5) produced signiﬁcantly less HIV-1
p24 antigen as compared to nontransfected HIV-1LAV (X4) or HIV-1BaL
(R5) infected PBMC (Tjernlund et al., 2007). Taken together with
these ﬁndings, our results imply that IL-6 and STAT3 can modulate
HIV-1 infection in cord and adult cells.While HIV-1 infected infants have a high viral load and progress to
symptomatic AIDS more rapidly than adults, the mechanisms of the
differential HIV disease are not known. We have provided some
evidence before showing that HIV-1 replicates more efﬁciently in
neonatal than adult cells (Sundaravaradan et al., 2006). Here we
provide additional data that support the notion that differential levels
of host factors and their interactions with HIV-1 contribute to higher
levels of HIV-1 gene expression and replication in neonatal vs. adult
cells. While HIV disease is multifactorial in nature, the new
information on the role of host factors provided in this study likely
contributes to a better understanding of differential HIV-1 patho-
genesis and disease progression in neonates and adults.
Materials and methods
Cord and adult blood donors
We have collected cord blood and adult blood from ﬁve to seven
donors under similar conditions. Cord and adult blood samples were
collected around the same time and processed side by side. In general
cord blood samples are between 60 and 120 ml yielding 300–600
million mononuclear cells. Cord blood yields more mononuclear cells
than adult blood, so to obtain a comparable number of adult blood
mononuclear cells; we collected 150–200ml of adult blood. This study
was approved by theUniversity of ArizonaHumanSubjects Committee
and written informed consent was obtained from all donors.
Isolation and culture of cord and adult blood mononuclear cells
We isolated peripheral blood mononuclear cells (PBMC) from
adult blood and cord blood mononuclear cells (CBMC) from cord
blood by a single step Ficoll-Hypaque density gradient method
(Matala et al., 2001). Equal number of PBMC and CBMC were plated
in six-well plates to perform Microarray and EMSA experiments.
Freshly isolated PBMC and CBMC were used as unstimulated cells and
were immediately processed for RNA isolation formicroarray analysis.
Stimulated PBMC/CBMC were obtained by culture for 24–48 h in
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of PHA. Post stimulation, PBMC/CBMC were infected with HIV-1BaL
and cultured in RPMI with 10% FBS, penicillin-streptomycin and
supplemented with 10 U/ml of IL2 and 100 U/ml of M-CSF.
Viruses and infection
HIV-1 isolate, HIV-1BaL, cell lines (COS-1), and other HIV related
reagents used have been obtained from NIH AIDS Research and
Reference Reagent Program (Germantown, MD). Pseudotyped virus,
HIV-NL-Luc-E-R+ was also used to infect cells to study HIV-1 gene
expression (Connor et al., 1995). Brieﬂy, CBMC and PBMC (60×106)
were infected after 24–48 h of PHA stimulation with equal amounts of
viruses normalized using RT assay counts (Matala et al., 2001). The
cells to be infected were incubated with HIV-1BaL (30,000 cpm/106
cells) and HIV-NL-Luc-E-R+ virus (25,000 cpm/106 cells). Two hours
post-infection, thewellswerewashedwith PBS to remove unadsorbed
virus and cells were fed with complete RPMI (RPMI 1640, 10% FBS, 1%
penicillin–streptomycin supplemented with IL-2 and MCSF). The cells
were harvested after 3 days to isolate RNA formicroarray experiments.
Gene expression
HIV-1 LTR based gene expression as measured by a luciferase
reporter (Connor et al., 1995)was estimated in CBMC and PBMCprior to
performing every microarray experiment. CBMC and PBMC 4×106 of
each were used for every experiment that was performed in duplicate.
As mononuclear cells consist of both suspension and adherent cells, the
two populations were separated to allow for ease of infection and were
fed with media used to feed the complete mononuclear cell population
(complete RPMI with IL-2 and MCSF). The separated cells were
stimulated and infected with HIV-1-NL-Luc-E-R+ virus as described
before (Sundaravaradan et al., 2006). 72 h post-infection the two cell
populationswere lysed separately and luciferase activitywas estimated.
RNA isolation
To isolate RNA from unstimulated cells, 60×106 CBMC and PBMC
from ﬁve donors were collected immediately after mononuclear cell
isolation, washed with PBS and lysed with 600 μl of RLT buffer (QIAgen
Inc.). DNAwas shredded using QIAshredder columns (QIAgen Inc.) and
RNAwas extracted from this shredded lysate using the RNeasy Mini kit
(QIAgen Inc.) according to manufacturer's protocols. This sample was
termed as unstimulated (US) RNA. To isolate RNA from stimulated or
infected cells, the suspensioncells fromstimulatedor infected cellswere
collected from all the wells for each experiment and washed with PBS.
The adherent cells were also washed with PBS. The pooled suspension
cells were lysed in 600 μl of RLT buffer. The adherent cells were also
lysed in 600 μl of RLT buffer by transferring lysate from one well to the
next. The shredded lysate (using QIAshredder columns) from suspen-
sion cells and adherent cells were mixed and RNA extracted using the
RNeasy Mini kit according to manufacturer's protocols. RNA from
stimulated un-infected cells was termed as stimulated mock RNA (SM)
and infected samples were labeled according to type of virus used. To
avoid RNA degradation, 1–2 μl of RNAseOUT recombinant RNAse
inhibitor (Invitrogen) was added to each sample.
RNA quantitation, precipitation and quality estimation
The amount of RNA was quantiﬁed using a NanoDrop (Thermo
Scientiﬁc Inc.). RNA was then concentrated by precipitation using
1/10th volume of 3 M sodium acetate and 2 volumes of chilled
absolute ethanol and resuspended in DEPC water. The RNA samples
fromUS, SMand infected samples of PBMC andCBMCwere testedwith
the BioAnalyzer at the Microarray Core Facility to ensure RNA stability
using 18S and 28S RNA peaks as indicators.Microarray hybridization
Differential gene expression of PBMC and CBMC was carried out by
the two-color ﬂuorescence hybridization scheme. The unstimulated
(US) samples of CBMC and PBMC were hybridized on one chip, the
stimulatedmock (SM) samples on one chip and the infected samples on
one chip. The labeling, hybridization andacquiringof imageswasdoneat
the core facility of the Arizona Research Laboratories (Univ. of Arizona).
The RNA samples were labeled with Aminoallyl dNTPs and then
conjugated with Cy3 (PBMC RNA) and Cy5 (CBMC RNA) ﬂuorochromes.
A pre-printed in-house 22K human genome chip was used to perform
the microarray with appropriate housekeeping and non-speciﬁc con-
trols. The RNA was hybridized with the chip and washed appropriately.
The array was scanned at two wavelengths following independent
excitation with an Array WoRx Scanner (Applied Precision).
Microarray data analysis
Two ﬁles obtained from the Array WoRx Scanner containing
intensity values for each slide read at 595 and 685 nm, respectively,
wereused. The spot-ﬁnding and intensity quantiﬁcationwasdoneusing
the SoftWorX™ tracker program (Applied Precision Inc.). Each spot
highlighted by the program was individually examined and spots that
were ‘abnormal’ (due to poor hybridization, dust or other experimental
errors)wereﬂagged. Theﬂuorescent intensity associatedwith each spot
was then annotated with the gene number, name and other data
associatedwith the cDNAprinted on the chip. All information associated
with each spotwas uploaded into Gene Spring (SiliconGenetics Inc.) for
the 22K human genome. The spots were normalized by LOWESS
normalization (Bolstad et al., 2003; Schena, 1996). This intensity
dependent normalization was used to eliminate dye-related artifacts
in two-color experiments. Thedatawas reported as thenormalized ratio
of Cy5 against Cy3. The expression level of genes in CBMCandPBMCwas
represented as a scatter plot with CBMC on the Y-axis and PBMC on the
X-axis. Diagonal lines are used to identify fold change lines. Spots
present between certain fold lines were used to generate separate ‘gene
lists’ of upregulated or downregulated genes. The spot intensity data
from the unstimulated stimulated and infection slides are loaded
together as grouped data. The genes upregulated in CBMC US sample
(CUS) are compared to the PBMC US (AUS) samples as US samples are
hybridized on the same slide. Comparison was also done for each cell
type in different test conditions such as US, SM and infected samples as
the data were uploaded together. The gene lists from comparisons of
CUS/AUS sampleswas compared by Venn diagrammethod to the CSM/
ASM gene lists and infected sample gene list to identify genes are
exclusive for one set or genes that are seen in more than one set. Gene
Spring (Silicon Genetics Inc.) also estimates statistical signiﬁcance (t-
test) of fold changes obtained.
cDNA synthesis and quantitative real-time PCR
Real-time RT-PCR was performed using the two-step qRT-PCR kit
with SYBR-Green and ROX (Invitrogen Inc.) according to manufac-
turer's protocols. RNA from unstimulated, stimulated and infected
CBMC and PBMC, or T cell lines was reverse transcribed with Super-
script III™ RT (Invitrogen), Oligo dT (20), randomhexamers, MgCl2 and
dNTPs at 42 °C for 50 min, followed by an inactivation step at 85 °C for
5 min according to manufacturer's protocols. The RNA from the RNA:
DNA hybrids was removed by treatment with RNase H at 37 °C for
20 min. The resulting cDNA was then ampliﬁed by gene speciﬁc
primers for real-time PCR by the SYBR-Green PCRmix (Invitrogen Inc.)
which consisted of Platinum® TaqDNApolymerase, SYBR®Green I dye,
ROX reference dye, Tris-HCl, KCl, 6 mM MgCl2, 400 μM dGTP, 400 μM
dATP, 400 μM dCTP, 800 μM dUTP, uracil DNA glycosylase (UDG), and
stabilizers. Primer efﬁciency for each primer set was tested and primer
sets with greater than 85% efﬁciency and single dissociation peaks
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for each gene speciﬁc primer tested to estimate the detection limit of
the primer. Housekeeping gene, GAPDH, was used as a background
control for CBMC and PBMC. Each CBMC and PBMC sample was run in
triplicate to ensure accurate fold change estimation. Relative gene
expression was calculated by the ΔΔCt method (Bassett et al., 2004).
Brieﬂy, Ct values for the gene of interest andGAPDHwas obtained from
each sample of CBMC and PBMC RNA and the Ct value of the gene-of-
interest was normalized to the Ct value of GAPDH. Final results are
expressed as n-fold difference in expression of gene-of-interest
relative to GAPDH gene for CBMC (ΔCt CBMC) and PBMC (ΔCt PBMC)
as n-fold=2^−(ΔCt CBMC −ΔCt PBMC). The real-time PCR quantiﬁ-
cation was done in the ABI 3700 equipment at the Arizona Research
Laboratories.
Preparation of nuclear extracts
Equal number of CBMC and PBMC from seven donors were either
unstimulated or stimulated with 3 μg/mL PHA. Nuclear extracts were
collected as per manufacturer's protocol (Active Motif). Brieﬂy,
unstimulated and stimulated cells were collected after 48 h and
washed with ice-cold PBS/phosphatase inhibitors, followed by
resuspension in 1× hypotonic buffer. Detergent was added, and this
gave yield to the cytoplasmic fraction. The nuclear pellet was
resuspended in complete lysis buffer and allowed to incubate on ice
for 30 min on a rocking platform. After incubation the suspension was
centrifuged and the nuclear extract was transferred to pre-chilled
tubes and stored at −80 °C. Nuclear extract protein concentrations
were determined using BioRad Bradford protein assay kit.
Electrophoretic mobility shift assays (EMSAs)
The nuclear extract prepared from CBMC and PBMC were used to
determine the levels of binding to LTR transcription factor sites. The
probes were annealed using a decreasing temperature scale of 5 °C
starting at 90 °C and ending at 20 °C.
The sequences of the probes are as follows:
NF-κB (+) 5′-AGGGACTTTCCGCTGGGGACTTTCCA-3′
NF-κB (−) 5′-TGGAAAGTCCCCAGCGGAAAGTCCCT-3′
NF-IL6 (+) 5′-AGCATTTCGTCCACA-3′
NF-IL6 (−) 5′-TGTGACGAAATGCT-3′
Sp1 (+) 5′-GAGGCGTGGCCTGGGCGGGACTGGGGAGTGGCG-3′
Sp1 (−) 5′-CGCCACTCCCCAGTCCCGCCCAGGCCACGCCTC-3′
NFAT (+) 5′-TGAGAGAGAAGTGTTA-3′
NFAT (−) 5′-TAACACTTCTCTCTCA-3′
AP-1 (+) 5′-CAGGGCCAGGGGTCAGATATCCACTGACCTTTGGA-
TGGTGCT-3′
AP-1 (−) 5′-AGCACCATCCAAAGGTCAGTGGATATCTGACCCC-
TGGCCCTG-3′
After annealing, probes were end labeled with 32P [γATP]
(Amersham Biosciences) using T4 Kinase (Invitrogen) and were
puriﬁed through a G25 column (Princeton Separations). Probes were
then counted in a scintillation counter to determine cpm.
Binding reaction
10–20 μg of protein from the nuclear extract was incubated with
Buffer D (20 mM HEPES, 20% v/v glycerol, 0.2 mM EDTA, 0.1M KCl,
and 0.5 mM PMSF and 1 mMDTT was added just before use), 50 μg/μl
BSA, 0.1M MgCl2 and 3 μg of poly dI:dC at room temperature for
15 min. After 15 min 50,000 cpm of probe was added and allowed to
incubate for 15 additional minutes. Tracking dye (Buffer D and
bromophenol blue) was added to the probe only sample and allreactions were resolved on 5% nondenaturing polyacrylamide gel
(30% acrylamide, 10× TBE, water, 20% glycerol, 10% APS, and TEMED).
While binding reaction is occurring the gel is pre-run for 90 min at
100 V in 4 °C. Samples are loaded and run for 90 min at 200 V at RT.
The gel was transferred to Whatman paper, dried and autoradio-
graphed. The sequence speciﬁcity of the binding reactions was
determined by competitive EMSA using 10X and 100X the amount
of cold probe. Gel shift band intensities were conﬁrmed by using
ImageJ available at the National Institutes of Health website.
Generation of retroviral shRNA (short hairpin RNA)
Themodulation of cellular factors was done by creating a retroviral
vector, which contained the shRNA of interest. We used Phoenix cells,
which were created by Dr. Nolan at Stanford (gift from Dr. Lonnie
Lybarger). Phoenix cells are a second generation retrovirus producer
line for the generation of amphotropic retroviruses (http://www-
leland.stanford.edu/group/nolan). These cells have been stably
transfected with gag-pol, and an amphotropic envelope, MuLV.
From the microarray data analysis, accession numbers for IL-6 and
STAT3 were obtained. These accession numbers (IL6-NM_000600 and
STAT3-AA399410) were entered into a computer platform from
OligoEngine (OligoEngine, Seattle, WA) to obtain an optimal 19-mer
nucleotide sequence, which may downregulate, these proteins. The
19-mer DNA sequences were as follows: IL-6-CTAGATGCAATAAC-
CACCC, STAT3-GGCGCCTCAGTCGTATCTT. After design, according to
manufacturer's instructions a sense and anti-sense 60 nucleotide
hairpin sequence, ﬂanked with BglII and HindIII sites, was derived for
each 19-mer obtained with the following sequences (19-mer sense
and anti-sense in bold and underlined):
IL-6- (+) 5′ GATCCCCCTAGATGCAATAACCACCCTTCAAGAGA-
GGGTGGTTATTGC ATCTAGTTTTTA 3′
IL-6- (−) 5′ AGCTTAAAAACTAGATGCAATAACCACCCTCTCTTGAA-
GGGTGGTTA TTGCATCTAGGGG 3′
STAT3- (+) 5′ GATCCCCGGCGCCTCAGTCGTATCTTTTCAAGAGA-
AAGATACGACT GAGGCGCCTTTTTA 3′
STAT3- (−) 5′AGCTTAAAAAGGCGCCTCAGTCGTATCTTTCTCTTGAA-
AAGATACGA CTGAGGCGCCGGG 3′
These 60 nucleotide forward and reverse oligonucleotides were
then annealed using a decreasing temperature scale of 5 °C starting at
90 °C and ending at 20 °C to yield a ﬁnal concentration of 0.2 μg/μl.
After annealing, cloning into a linearized pSUPER RNAi retroviral
system (OligoEngine, Seattle, WA) was performed. Brieﬂy, the
pSUPER RNAi vector was linearized using BglII (Invitrogen) and Hin-
dIII (Invitrogen) in a total volume of 50 μl. The linearized vector and
annealed oligonucleotides were then ligated using T4 DNA ligase
(Invitrogen) overnight at room temperature and transformed into
DH5α subcloning efﬁciency E. coli cells (Invitrogen). After transfor-
mation, colonies were screened using restriction enzyme digestion
and sequencing was performed to ensure that the correct DNA
sequence was cloned for transfections. Brieﬂy, 8×105 Phoenix cells
were plated in six-well plates 4 h prior to transfection. After 4 h 10 μg
of plasmid DNA was added to serum free media (Invtirogen) and
Fugene 6 (Roche) in a total volume of 100 μl and allowed to incubate
for 30 min at room temperature. After incubation 100 μl was added
drop wise to the cells and 24 h later the media was removed and
replaced with fresh media. Forty-eight hours after transfections,
media was harvested and reverse transcriptase (RT) assays were
performed as previously described (Matala et al., 2001).
Modulation of cellular factors using shRNA in cell lines and primary cells
T-lymphocyte cell line A3.01 were counted and plated at 500,000
cells per well. For primary cells: CD4+ enriched T-lymphocytes from
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(Invitrogen) and infected with 50,000 cpm of the shRNA retrovirus in
a ﬁnal volume of 150 μl and allowed to adsorb for 2 h at 37 °C. After
2 h, unadsorbed virus was washed off and cells were fed with
complete RPMI (RPMI 1640, 10% FBS and 1× penicillin/streptomycin)
and incubated for 12 h at 37 °C for shRNA-mediated downregulation
for the gene of interest. After 12 h, the cells were then washed to
remove the complete RPMI, resuspended in RPMI alone and infected
with 50,000 cpm of the HIV-1 pseudovirus (HIV NL-Luc-E-R+) in a
ﬁnal volume of 150 μl and allowed to adsorb for 2 h at 37 °C. After 2 h,
unadsorbed virus was washed off and cells were fed with complete
RPMI and incubated for 72 h at 37 °C. After 72 h, RNA was isolated
(described above) for quantitation of gene speciﬁc down-modulation
using a SuperScript III One-Step RT-PCR System, with α-tubulin
serving as internal housekeeping control. Brieﬂy, 0.2 μg of RNA was
added to a master mix of 2× reaction mix, 10 μM of sense and anti-
sense gene speciﬁc primers, 1 μl of SuperScript III RT/Platinum Taq in
a ﬁnal volume of 25 μl in DEPC water. 2–5 μl of PCR product was
analyzed on a 1.2% agarose gel and the band intensities were
quantiﬁed. Protein was also extracted and luciferase assays was
performed (as described above).
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